Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
World Journal of Gastroenterology|March 4, 2014
Immunotherapy in gastric cancerSatoko Matsueda, David Y GrahamCancer Science|February 2, 2018
Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinaseSatoko Matsueda, Kyogo Itoh, Shigeki ShichijoCancers|May 13, 2023
Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor TissueYoshimi Arima, Satoko Matsueda, Hideyuki SayaJapanese Journal of Helicobacter Research|January 3, 2017
Changing the natural history of metachronous gastric cancer after H. pylori eradicationDavid Y Graham, Satoko Matsueda, Akiko ShiotaniAdvances in Experimental Medicine and Biology|July 25, 2019
Cellular Immunotherapy in the Treatment of Hematopoietic MalignanciesSatoko Matsueda, Thinle Chodon, Richard C KoyaJournal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Vaccination of cytotoxic T lymphocyte-directed peptides elicited and spread humoral and Th1-type immune responses to prostate-specific antigen protein in a prostate cancer patientMamoru Harada, Satoko Matsueda, Akihisa Yao, et al.International Journal of Oncology|September 6, 2005
Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor typesYoshimi Arima, Satoko Matsueda, Hirohisa Yano, et al.Cancer Immunology, Immunotherapy : CII|September 12, 2024
Recent clinical researches and technological development in TIL therapySatoko Matsueda, Lei Chen, Hongmei Li, et al.Oncology Reports|May 24, 2008
HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells: The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptorYufeng Li, Satoshi Ishiyama, Satoko Matsueda, et al.Pageof 9